TRIPLE-CLASS REFRACTORY MULTIPLE MYELOMA

Clinical trials for TRIPLE-CLASS REFRACTORY MULTIPLE MYELOMA explained in plain language.

Never miss a new study

Get alerted when new TRIPLE-CLASS REFRACTORY MULTIPLE MYELOMA trials appear

Sign up with your email to follow new studies for TRIPLE-CLASS REFRACTORY MULTIPLE MYELOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Cancer trial tests 'Less is More' approach for Tough-to-Treat myeloma

Disease control Recruiting now

This study is testing whether doctors can safely lower the dose and frequency of a cancer drug called linvoseltamab for patients with multiple myeloma that has returned or stopped responding to other treatments. The goal is to see if less medicine can still control the cancer whi…

Matched conditions: TRIPLE-CLASS REFRACTORY MULTIPLE MYELOMA

Phase: PHASE1, PHASE2 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control

Last updated Mar 23, 2026 15:17 UTC

TRIPLE-CLASS REFRACTORY MULTIPLE MYELOMA

Get alerted when new TRIPLE-CLASS REFRACTORY MULTIPLE MYELOMA trials appear

Cancer trial tests 'Less is More' approach for Tough-to-Treat myeloma